94 related articles for article (PubMed ID: 2553475)
1. Tumour markers in the clinical management of patients with small cell lung cancer.
Hansen M; Hansen HH
Eur Respir J; 1989 Sep; 2(8):700-1. PubMed ID: 2553475
[No Abstract] [Full Text] [Related]
2. Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer.
Scagliotti GV; Piani M; Gatti E; Gozzelino F; Albera C; Pozzi E
Eur Respir J; 1989 Sep; 2(8):746-50. PubMed ID: 2553476
[TBL] [Abstract][Full Text] [Related]
3. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Schneider J; Philipp M; Salewski L; Velcovsky HG
Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
[TBL] [Abstract][Full Text] [Related]
4. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
5. [Plasma gastrin-releasing peptide analysis and the clinical significance].
Maruno K; Yamaguchi K; Abe K
Nihon Rinsho; 1990 Feb; 48 Suppl():100-3. PubMed ID: 2162407
[No Abstract] [Full Text] [Related]
6. Value of tumour and inflammatory markers in lung cancer.
Oremek GM; Sauer-Eppel H; Bruzdziak TH
Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer].
Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525
[No Abstract] [Full Text] [Related]
8. [Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer].
Kushlinskiĭ NE; Liubimova NV; Lemeshko AO; Vasil'ev AV; Davydov MI
Biull Eksp Biol Med; 1997 Jan; 123(1):98-100. PubMed ID: 9213472
[No Abstract] [Full Text] [Related]
9. [Serum neuron-specific enolase (NSE) in patients with primary lung cancer].
Oribe H; Kato R; Noguchi S; Kai T
Rinsho Byori; 1988 Apr; 36(4):464-8. PubMed ID: 2841516
[No Abstract] [Full Text] [Related]
10. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
Oremek GM; Sapoutzis N
Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319
[TBL] [Abstract][Full Text] [Related]
11. [Biological markers in lung cancer].
Nikliński J; Furman M
Pneumonol Alergol Pol; 1991; 59(5-6):253-9. PubMed ID: 1668877
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
[No Abstract] [Full Text] [Related]
13. [Neuron specific enolase (NSE)].
Odagiri E
Nihon Rinsho; 1999 Dec; 57 Suppl():540-2. PubMed ID: 10778185
[No Abstract] [Full Text] [Related]
14. Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer.
Spinazzi A; Soresi E; Borghini U; Boffi R; Vigorelli R; Scoccia S
J Nucl Med Allied Sci; 1990; 34(4 Suppl):141-5. PubMed ID: 1965446
[No Abstract] [Full Text] [Related]
15. [Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase].
Maruno K
Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):760-5. PubMed ID: 2169019
[TBL] [Abstract][Full Text] [Related]
16. [Tumor markers in lung cancer].
Niho S; Shinkai T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
Yang J; Li R; Li A
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of serum NSE assay as a tumor marker].
Ariyoshi Y; Kuwabara M
Nihon Rinsho; 1990 Feb; 48 Suppl():1035-7. PubMed ID: 2162410
[No Abstract] [Full Text] [Related]
19. [Pro gastrin-releasing peptide (ProGRP)].
Ishikawa H; Saito T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():759-61. PubMed ID: 16149633
[No Abstract] [Full Text] [Related]
20. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
Satoh H; Kagohashi K; Kurishima K; Ishikawa H; Ohtsuka M
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):720. PubMed ID: 17100161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
